|
Barr Pharmaceuticals, Inc.
Ticker Symbol: BRL* CUSIP: 068306109 Exchange: NYSE
* NOTE: This security is no longer trading as of 12/23/08
Company's Online Profile
BUSINESS: Barr Laboratories, Inc. is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals.
|
Notes: On December 23, 2008, Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) completed its acquisition of Barr Pharmaceuticals, Inc. As a result of the acquisition, Barr Pharmaceuticals, Inc. has been de-listed from the New York Stock Exchange.
|
IPO - 1/1/1900
Previous Name: Barr Laboratories, Inc. Changed: 12/31/03
Large Cap Stock -
Market Value $ 3 Billion
Yahoo News Summary for BRL*
YAHOO! Profile for BRL*
Yahoo Detailed Quote
MarketWatch Quote
MSN Company Report for BRL*
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: Two Quaker Road, Pomona, NY 10970 |
| Main Phone Number |
845-362-1100 |
| Fax Number |
845-353-3843 |
| Corporate Communications
Carol A. Cox
|
845-348-6808
|
| Toll Free Phone Number |
800-227-7522 |
| CEO - Bruce L. Downey |
CFO - William T. McKee |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
